Skip to main content

Marc Ribó Jacobi

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Marc Ribó Jacobi

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Projects

European Stroke Research Network for Hypothermia (EUROHYP-1) Grant Agreement nº 278709

IP: Carlos Molina Cateriano
Collaborators: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, Estela Sanjuan Menendez, Marc Ribó Jacobi, Maria Pilar Meler Amella, David Rodriguez Luna, Mª Ángeles Muchada López
Funding agency: EUROPEAN COMMISSION
Funding: 655474
Reference: 'EUROHYP-1_FP7HEALTH2011
Duration: 01/02/2012 - 31/07/2018

Neuroprotección mediante sistema de "perfusión artificial" de la penunbra isquémica con sangre arterial oxigenada

IP: Marc Ribó Jacobi
Collaborators: Marta Aurora Rubiera Del Fueyo
Funding agency: Instituto de Salud Carlos III
Funding: 77440
Reference: PI09/01660
Duration: 01/01/2010 - 30/06/2014

Grup de Recerca en Malalties Neurovasculars

IP: Joan Montaner Villalonga
Collaborators: Raquel Arias Gonzalez, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, Manuel Quintana Luque
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 46800
Reference: 2009 SGR 432
Duration: 01/01/2010 - 30/04/2014

Estrategias para mejorar la eficacia y seguridad del tratamiento con Simvastatina en la Fase Aguda del Ictus Isquémico: STARS trial

IP: Joan Montaner Villalonga
Collaborators: Marta Aurora Rubiera Del Fueyo, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Olga Maisterra Santos, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Estevo Santamarina Pérez
Funding agency: Instituto de Salud Carlos III
Funding: 175450
Reference: EC07/90195
Duration: 01/11/2007 - 30/06/2012

Related news

UMBRELLA, a consortium of over 20 public and private partners, kicks off this week with the aim of revolutionising the entire stroke care pathway in Europe by adopting a holistic approach that covers stroke diagnosis, prevention and care.

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

Related professionals

Victor Monforte Torres

Victor Monforte Torres

Main researcher
Pneumology
Read more
Blanca Joseph Mullol

Blanca Joseph Mullol

Research technician
Rheumatology
Read more
Cristina Aguilar Riera

Cristina Aguilar Riera

Growth and Development
Read more
Montserrat Fabregat Garcia

Montserrat Fabregat Garcia

Research technician
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.